Intellia Therapeutics Inc (NASDAQ: NTLA) – Suitable For Long Term Buy?
Currently, there are 103.54M common shares owned by the public and among those 97.42M shares have been available to trade. The company’s stock has a 5-day price change of 18.55% and 67.72% over the past three months. NTLA shares are trading -51.55% year to date (YTD), with the 12-month market performance down to -4.63% lower. […]
Intellia Therapeutics Inc (NTLA) Outlook Starting To Look Brighter?
Intellia Therapeutics Inc (NTLA) concluded trading on Wednesday at a closing price of $10.73, with 7.23 million shares of worth about $77.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.36% during that period and on July 02, 2025 the price saw a […]
These Numbers Could Change Investor Views For Intellia Therapeutics Inc (NASDAQ: NTLA)
Currently, there are 103.54M common shares owned by the public and among those 97.48M shares have been available to trade. The company’s stock has a 5-day price change of 13.11% and 4.24% over the past three months. NTLA shares are trading -17.84% year to date (YTD), with the 12-month market performance down to -63.10% lower. […]
Value Hunters: Look To Intellia Therapeutics Inc (NTLA)
Currently, there are 103.54M common shares owned by the public and among those 97.48M shares have been available to trade. The company’s stock has a 5-day price change of 10.14% and -8.92% over the past three months. NTLA shares are trading -27.36% year to date (YTD), with the 12-month market performance down to -63.09% lower. […]
Intellia Therapeutics Inc (NASDAQ: NTLA) Is Getting Increasingly Hard To Ignore
Currently, there are 103.54M common shares owned by the public and among those 97.48M shares have been available to trade. The company’s stock has a 5-day price change of -21.83% and -24.23% over the past three months. NTLA shares are trading -38.59% year to date (YTD), with the 12-month market performance down to -66.96% lower. […]
Institutional Exposure To Intellia Therapeutics Inc (NTLA)
Intellia Therapeutics Inc (NTLA) concluded trading on Thursday at a closing price of $7.45, with 24.19 million shares of worth about $180.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -47.90% during that period and on May 29, 2025 the price saw a […]
Intellia Therapeutics Inc (NTLA): A Great Stock For Handling Current Market Conditions?
Currently, there are 103.54M common shares owned by the public and among those 97.48M shares have been available to trade. The company’s stock has a 5-day price change of 16.23% and -21.25% over the past three months. NTLA shares are trading -17.07% year to date (YTD), with the 12-month market performance down to -63.05% lower. […]